Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsWhile discussions on social media is one way to engage the public in policymaking, the powers that be should not wait for a problematic policy to go viral, and instead involve public participation before as part of the process.
In terms of the availability of new medicines, Indonesia ranks the lowest among Asia-Pacific countries and members of the Group of 20, standing at only 9 percent out of 460 new medicines launched globally between 2012 and 2021.
Despite being on a declining trend since the 1998 Asian financial crisis, credit cost in Indonesia still remains the highest in ASEAN-5, and a different policy approach is needed to make the banking sector more competitive.